Trial Profile
Repaglinide Versus Glyburide: Comparitive Effect on Postprandial Lipemia: An Open-labeled, Randomized, Parallel Group Study in Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2017
Price :
$35
*
At a glance
- Drugs Repaglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 20 Apr 2015 New trial record